Walleye Capital
ALT icon

Walleye Capital’s Altimmune ALT Stock Holding History

Walleye Capital’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.46K Sell
800
-2,700
-77% -$11.5K ﹤0.01% 4228
2025
Q4 		$12.6K Buy
3,500
+3,300
+1,650% +$14.4K ﹤0.01% 4287
2025
Q3 		$754 Sell
200
-8,800
-98% -$34K ﹤0.01% 4383
2025
Q2 		$34.8K Buy
+9,000
New +$48.7K ﹤0.01% 4132
2025
Q1 		– Sell
-8,400
Closed -$60.6K – 4194
2024
Q4 		$60.6K Buy
+8,400
New +$64.2K ﹤0.01% 4306
2024
Q3 		– Sell
-15,300
Closed -$102K – 5221
2024
Q2 		$102K Buy
15,300
+13,900
+993% +$103K ﹤0.01% 4706
2024
Q1 		$14.3K Buy
+1,400
New +$14.2K ﹤0.01% 4998
2022
Q4 		– Sell
-3,200
Closed -$41K – 3146
2022
Q3 		$41K Buy
+3,200
New +$47.2K ﹤0.01% 2629

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Walleye Capital's ALT Position: Q1 2026 in Review

Walleye Capital reduced its Altimmune (ALT) stake by 100% in Q1 2026, selling an estimated $279K and leaving 2 shares worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #4313.

Walleye Capital first reported a position in ALT in Q4 2021 and has held it in 12 quarters since. The position peaked at $1.58M in Q2 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Walleye Capital held 2 shares of Altimmune worth $6 as of Q1 2026.
  • Walleye Capital sold 65,663 Altimmune shares in Q1 2026, an estimated $279K.
  • Altimmune made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4313 holding.
  • Walleye Capital first reported a position in Altimmune in Q4 2021 and has held it in 12 quarters since.
  • Walleye Capital's Altimmune position peaked at $1.58M in Q2 2022.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.